|Share Name||Share Symbol||Market||Type||Share ISIN||Share Description|
|GlaxoSmithKline||LSE:GSK||London||Ordinary Share||GB0009252882||ORD 25P|
|Price Change||% Change||Share Price||Bid Price||Offer Price||High Price||Low Price||Open Price||Shares Traded||Last Trade|
|Industry Sector||Turnover (m)||Profit (m)||EPS - Basic||PE Ratio||Market Cap (m)|
|Pharmaceuticals & Biotechnology||27,889.0||1,939.0||18.8||89.2||82,347.31|
GlaxoSmithKline Submits US Application To Expand Fluarix Indication
GlaxoSmithKline PLC on Wednesday said it has submitted a supplemental Biologics License application to expand the indication for its flu vaccine...
Subscribe now to see this Premium News article from
Alliance News Professional covers every UK stock in your portfolio. It goes beyond regulatory news and free web services to give your investment decisions an edge over the crowd.
- In The Know - Management and analyst comments that go beyond company announcements.
- Flash headlines on all 2,400 London-listed companies before the news hits the open web.
- Broker Ratings - The earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and eurozone.
- Taking AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £36 per month, and cancel at any time.
Call us on 0207 0700 961 to get started.
1 Year GlaxoSmithKline Chart
1 Month GlaxoSmithKline Chart